Cara Therapeutics | CARA - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Cara Therapeutics USD 2.09M 96K 2026-03
Cassava Sciences USD 3.89M 2.77M 2026-03
Chugai Pharma JPY 32.37B 3.32B 2026-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 57M 10.71M 2026-06
J&J USD 6.25B 168M 2026-09
Neurocrine Biosciences USD 383.1M 64.6M 2026-06
Pacira USD 91.81M 7.93M 2026-06
Pfizer USD 3.41B 496M 2026-06
RedHill Biopharma USD 4.48M 1.52M 2024-03
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12